These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21569324)

  • 1. Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.
    Ishikawa N; Mazur W; Toljamo T; Vuopala K; Rönty M; Horimasu Y; Kohno N; Kinnula VL
    BMC Pulm Med; 2011 May; 11():22. PubMed ID: 21569324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
    Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
    APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
    Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
    Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
    Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
    Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.
    Ohlmeier S; Mazur W; Linja-Aho A; Louhelainen N; Rönty M; Toljamo T; Bergmann U; Kinnula VL
    J Proteome Res; 2012 Feb; 11(2):599-608. PubMed ID: 22053820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased human Ca²⁺-activated Cl⁻ channel 1 expression and mucus overproduction in airway epithelia of smokers and chronic obstructive pulmonary disease patients.
    Iwashita H; Fujimoto K; Morita S; Nakanishi A; Kubo K
    Respir Res; 2012 Jun; 13(1):55. PubMed ID: 22731784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T
    Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and COPD increase sputum levels of extracellular superoxide dismutase.
    Regan EA; Mazur W; Meoni E; Toljamo T; Millar J; Vuopala K; Bowler RP; Rahman I; Nicks ME; Crapo JD; Kinnula VL
    Free Radic Biol Med; 2011 Aug; 51(3):726-32. PubMed ID: 21621610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
    Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
    Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease.
    Peltoniemi MJ; Rytilä PH; Harju TH; Soini YM; Salmenkivi KM; Ruddock LW; Kinnula VL
    Respir Res; 2006 Oct; 7(1):133. PubMed ID: 17064412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of sputum and serum autoantibodies in patients with chronic obstructive pulmonary disease.
    Cass SP; Dvorkin-Gheva A; Yang Y; McGrath JJC; Thayaparan D; Xiao J; Wang F; Mukherjee M; Long F; Peng T; Nair P; Liang Z; Stevenson CS; Li QZ; Chen R; Stampfli MR
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1169-L1182. PubMed ID: 33908260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction.
    Ilumets H; Mazur W; Toljamo T; Louhelainen N; Nieminen P; Kobayashi H; Ishikawa N; Kinnula VL
    BMC Pulm Med; 2011 Apr; 11():19. PubMed ID: 21504569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
    Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
    Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking-associated increase in mucins 1 and 4 in human airways.
    Merikallio H; Kaarteenaho R; Lindén S; Padra M; Karimi R; Li CX; Lappi-Blanco E; Wheelock ÅM; Sköld MC
    Respir Res; 2020 Sep; 21(1):239. PubMed ID: 32948202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
    Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
    Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects.
    Titz B; Sewer A; Schneider T; Elamin A; Martin F; Dijon S; Luettich K; Guedj E; Vuillaume G; Ivanov NV; Peck MJ; Chaudhary NI; Hoeng J; Peitsch MC
    J Proteomics; 2015 Oct; 128():306-20. PubMed ID: 26306861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity.
    Harju T; Mazur W; Merikallio H; Soini Y; Kinnula VL
    Respir Res; 2008 Dec; 9(1):80. PubMed ID: 19077292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.
    Gao J; Ohlmeier S; Nieminen P; Toljamo T; Tiitinen S; Kanerva T; Bingle L; Araujo B; Rönty M; Höyhtyä M; Bingle CD; Mazur W; Pulkkinen V
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L17-26. PubMed ID: 25979078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation endproducts and their receptor in different body compartments in COPD.
    Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
    Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.